Onward Medical N.V. (ONWD) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.366x

Based on the latest financial reports, Onward Medical N.V. (ONWD) has a cash flow conversion efficiency ratio of -0.366x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-20.25 Million ≈ $-23.68 Million USD) by net assets (€55.32 Million ≈ $64.67 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Onward Medical N.V. market capitalisation for the company's overall valuation and market capitalisation.

Onward Medical N.V. - Cash Flow Conversion Efficiency Trend (2018–2025)

This chart illustrates how Onward Medical N.V.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Onward Medical N.V. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Onward Medical N.V. ranked by their cash flow conversion efficiency. See debt repayment capacity of Onward Medical N.V. to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
Silver Touch Technologies Limited NSE:SILVERTUC	-0.021x
Principal Capital Public Company Limited BK:PRINC	0.018x
RCI Hospitality Holdings Inc NASDAQ:RICK	0.051x
AG Mortgage Investment Trust Inc NYSE:MITT	0.037x
GENFIT S.A. ADR/1 EO-25 F:XUPB	N/A
Quang Viet Enterprise Co Ltd TW:4438	-0.156x
T-Robotics.Co.Ltd KQ:117730	-0.078x
Cyprium Metals Ltd AU:CYM	-0.068x

Annual Cash Flow Conversion Efficiency for Onward Medical N.V. (2018–2025)

The table below shows the annual cash flow conversion efficiency of Onward Medical N.V. from 2018 to 2025. View Onward Medical N.V. share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€55.32 Million ≈ $64.67 Million	€-39.07 Million ≈ $-45.67 Million	-0.706x	-6.85%
2024-12-31	€48.05 Million ≈ $56.18 Million	€-31.76 Million ≈ $-37.13 Million	-0.661x	+63.27%
2023-12-31	€17.93 Million ≈ $20.96 Million	€-32.27 Million ≈ $-37.73 Million	-1.800x	-254.95%
2022-12-31	€52.63 Million ≈ $61.53 Million	€-26.68 Million ≈ $-31.20 Million	-0.507x	-110.94%
2021-12-31	€82.68 Million ≈ $96.67 Million	€-19.87 Million ≈ $-23.23 Million	-0.240x	-159.80%
2020-12-31	€-32.09 Million ≈ $-37.52 Million	€-12.90 Million ≈ $-15.08 Million	0.402x	-39.07%
2019-12-31	€-14.92 Million ≈ $-17.45 Million	€-9.85 Million ≈ $-11.51 Million	0.660x	-5.33%
2018-12-31	€-10.27 Million ≈ $-12.01 Million	€-7.16 Million ≈ $-8.37 Million	0.697x	--

About Onward Medical N.V.

BR:ONWD Belgium Biotechnology

Market Cap

$235.32 Million

€201.29 Million EUR

Market Cap Rank

#16634 Global

#70 in Belgium

Share Price

€2.90

Change (1 day)

+0.17%

52-Week Range

€2.29 - €5.52

All Time High

€12.90